Methylprednisolone Acetate Injection — FDA Drug Shortage

Current — Pfizer Inc.

The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Pfizer Inc. with status Current. The shortage was first posted on Dec 15, 2021. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Pfizer Inc.
Package NDC
0009-3073-01
Dosage Form
Injection
Presentation
Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01)
Initial Posting
Dec 15, 2021

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.